Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
22 May 2023 |
Main ID: |
NCT03497156 |
Date of registration:
|
05/04/2018 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Bariatric Surgery and Pharmacokinetics of Lercanidipine
|
Scientific title:
|
Bariatric Surgery and Pharmacokinetics Lercanidipine: BAR-MEDS Lercanidipine |
Date of first enrolment:
|
November 2, 2016 |
Target sample size:
|
12 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT03497156 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Norway
| | | | | | | |
Contacts
|
Name:
|
Magnus Strømmen, MSc |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
|
Name:
|
Magnus Strømmen, MSc |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
St. Olavs University Hospital |
|
Name:
|
Magnus Strømmen, MSc |
Address:
|
|
Telephone:
|
0047 72829970 |
Email:
|
magnus.strommen@stolav.no |
Affiliation:
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Preparing to undergo gastric bypass or sleeve gastrectomy in Central Norway
- Being a Norwegian citizen
Exclusion Criteria:
- Having previously undergone resections in the GI-tract
Age minimum:
18 Years
Age maximum:
70 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Obesity, Morbid
|
Intervention(s)
|
Drug: Lercanidipine
|
Primary Outcome(s)
|
lercanidipine concentration in blood serum (area under curve (AUC))
[Time Frame: From baseline to 1 year postoperatively]
|
Secondary ID(s)
|
2016/1145r
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|